UCSD, TargeGen team-up on blood disease treatment
News | 04. 07. 2008
A one-year scientific collaboration that included the University of California San Diego and the tiny local biotechnology company TargeGen has moved a treatment for a potentially fatal blood disease into human trials at record speed.
© 2021 Pappas Capital, LLC. ALL RIGHTS RESERVED.
© 2018 Pappas Capital, LLC. ALL RIGHTS RESERVED.